Literature DB >> 24313304

Gas-phase ion isomer analysis reveals the mechanism of peptide sequence scrambling.

Chenxi Jia1, Zhe Wu, Christopher B Lietz, Zhidan Liang, Qiang Cui, Lingjun Li.   

Abstract

Peptide sequence scrambling during mass spectrometry-based gas-phase fragmentation analysis causes misidentification of peptides and proteins. Thus, there is a need to develop an efficient approach to probing the gas-phase fragment ion isomers related to sequence scrambling and the underlying fragmentation mechanism, which will facilitate the development of bioinformatics algorithm for proteomics research. Herein, we report on the first use of electron transfer dissociation (ETD)-produced diagnostic fragment ions to probe the components of gas-phase peptide fragment ion isomers. In combination with ion mobility spectrometry (IMS) and formaldehyde labeling, this novel strategy enables qualitative and quantitative analysis of b-type fragment ion isomers. ETD fragmentation produced diagnostic fragment ions indicative of the precursor ion isomer components, and subsequent IMS analysis of b ion isomers provided their quantitative and structural information. The isomer components of three representative b ions (b9, b10, and b33 from three different peptides) were accurately profiled by this method. IMS analysis of the b9 ion isomers exhibited dynamic conversion among these structures. Furthermore, molecular dynamics simulation predicted theoretical drift time values, which were in good agreement with experimentally measured values. Our results strongly support the mechanism of peptide sequence scrambling via b ion cyclization, and provide the first experimental evidence to support that the conversion from molecular precursor ion to cyclic b ion (M → (c)b) pathway is less energetically (or kinetically) favored.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24313304      PMCID: PMC4005837          DOI: 10.1021/ac401578p

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  49 in total

1.  Statistical analysis of ion mobility spectrometry. I. Unbiased and guided replica-exchange molecular dynamics.

Authors:  Fabien Chirot; Florent Calvo; Florian Albrieux; Jérôme Lemoine; Yury O Tsybin; Philippe Dugourd
Journal:  J Am Soc Mass Spectrom       Date:  2011-12-01       Impact factor: 3.109

2.  Effect of the His residue on the cyclization of b ions.

Authors:  Benjamin J Bythell; Michaela Knapp-Mohammady; Béla Paizs; Alex G Harrison
Journal:  J Am Soc Mass Spectrom       Date:  2010-05-13       Impact factor: 3.109

3.  The extent and effects of peptide sequence scrambling via formation of macrocyclic B ions in model proteins.

Authors:  Irine S Saminathan; X Simon Wang; Yuzhu Guo; Olga Krakovska; Sébastien Voisin; Alan C Hopkinson; K W Michael Siu
Journal:  J Am Soc Mass Spectrom       Date:  2010-09-09       Impact factor: 3.109

4.  Number of solution states of bradykinin from ion mobility and mass spectrometry measurements.

Authors:  Nicholas A Pierson; Liuxi Chen; Stephen J Valentine; David H Russell; David E Clemmer
Journal:  J Am Chem Soc       Date:  2011-08-15       Impact factor: 15.419

5.  Sequence-scrambling fragmentation pathways of protonated peptides.

Authors:  Christian Bleiholder; Sandra Osburn; Todd D Williams; Sándor Suhai; Michael Van Stipdonk; Alex G Harrison; Béla Paizs
Journal:  J Am Chem Soc       Date:  2008-12-31       Impact factor: 15.419

6.  Sequence elucidation of an unknown cyclic peptide of high doping potential by ETD and CID tandem mass spectrometry.

Authors:  Fuyu Guan; Cornelius E Uboh; Lawrence R Soma; Jeffrey Rudy
Journal:  J Am Soc Mass Spectrom       Date:  2011-02-18       Impact factor: 3.109

7.  Apparent inhibition by arginine of macrocyclic b ion formation from singly charged protonated peptides.

Authors:  Samuel P Molesworth; Michael J Van Stipdonk
Journal:  J Am Soc Mass Spectrom       Date:  2010-02-10       Impact factor: 3.109

8.  High-definition de novo sequencing of crustacean hyperglycemic hormone (CHH)-family neuropeptides.

Authors:  Chenxi Jia; Limei Hui; Weifeng Cao; Christopher B Lietz; Xiaoyue Jiang; Ruibing Chen; Adam D Catherman; Paul M Thomas; Ying Ge; Neil L Kelleher; Lingjun Li
Journal:  Mol Cell Proteomics       Date:  2012-10-01       Impact factor: 5.911

9.  Disfavoring macrocycle b fragments by constraining torsional freedom: the "twisted" case of QWFGLM b6.

Authors:  Marcus Tirado; Jochem Rutters; Xian Chen; Alfred Yeung; Jan van Maarseveen; John R Eyler; Giel Berden; Jos Oomens; Nick C Polfer
Journal:  J Am Soc Mass Spectrom       Date:  2012-01-05       Impact factor: 3.109

10.  CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields.

Authors:  K Vanommeslaeghe; E Hatcher; C Acharya; S Kundu; S Zhong; J Shim; E Darian; O Guvench; P Lopes; I Vorobyov; A D Mackerell
Journal:  J Comput Chem       Date:  2010-03       Impact factor: 3.376

View more
  2 in total

Review 1.  Mass Spectrometry Approaches Empowering Neuropeptide Discovery and Therapeutics.

Authors:  Krishna D B Anapindi; Elena V Romanova; James W Checco; Jonathan V Sweedler
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923

2.  Peptide scrambling during collision-induced dissociation is influenced by N-terminal residue basicity.

Authors:  Ross Chawner; Stephen W Holman; Simon J Gaskell; Claire E Eyers
Journal:  J Am Soc Mass Spectrom       Date:  2014-08-19       Impact factor: 3.109

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.